Characterization of peptide polymer interactions in poly(alkylcyanoacrylate) nanoparticles: A mass spectrometric approach

Current Drug Delivery

Volumn 7, Issue 3, 2010, Pages 208-215

  Kafka, Alexandra P ^a   Kleffmann, Torsten ^a   Rades, Thomas ^a   McDowell, Arlene ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Angiotensin; Covalent conjugation; GnRH; h ACTH; IGF 1; Insulin; MALDI TOF TOF; PACA

Indexed keywords

ANGIOTENSIN II; CORTICOTROPIN; CYANOACRYLATE; GLUTAMIC ACID; HISTIDINE; INSULIN; NANOPARTICLE; PEPTIDE; POLYMER; SOMATOMEDIN C; ANGIOTENSIN II, ASN(1)-VAL(5)-; CORTICOTROPIN[18-39]; CYANOACRYLATE DERIVATIVE; DRUG CARRIER; ENBUCRILATE; GONADORELIN; POLY(ETHYLCYANOACRYLATE);

ARTICLE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROEMULSION; MOLECULAR WEIGHT; PH; POLYMERIZATION; PRIORITY JOURNAL; ANALOGS AND DERIVATIVES; CHEMICAL STRUCTURE; CHEMISTRY; MATRIX-ASSISTED LASER DESORPTION-IONIZATION MASS SPECTROMETRY; MEDICINAL CHEMISTRY; NANOTECHNOLOGY; PROCEDURES; PROTEIN CONFORMATION;

ANGIOTENSIN II; CHEMISTRY, PHARMACEUTICAL; CORTICOTROPIN-LIKE INTERMEDIATE LOBE PEPTIDE; CYANOACRYLATES; DRUG CARRIERS; ENBUCRILATE; GLUTAMIC ACID; GONADOTROPIN-RELEASING HORMONE; HISTIDINE; HYDROGEN-ION CONCENTRATION; INSULIN; INSULIN-LIKE GROWTH FACTOR I; MODELS, MOLECULAR; NANOPARTICLES; NANOTECHNOLOGY; PEPTIDES; PROTEIN CONFORMATION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 77954670498     PISSN: 15672018     EISSN: None     Source Type: Journal    
DOI: 10.2174/156720110791560937     Document Type: Article

References (26)

1. Vauthier, C.; Dubernet, C.; Fattal, E.; Pinto-Alphandary, H.; Couvreur, P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv. Drug Deliv. Rev., 2003, 55(4), 519-548.
2. Couvreur, P.; Barratt, G.; Fattal, E.; Legrand, P.; Vauthier, C. Nanocapsule technology: A review. Crit. Rev. Ther. Drug Carrier Syst., 2002, 19(2), 99-134.
3. Allemann, E.; Leroux, J. C.; Gurny, R. Polymeric nano-and microparticles for the oral delivery of peptides and peptidomimetics. Adv. Drug Deliv. Rev., 1998, 34(2-3), 171-189.
4. Watnasirichaikul, S.; Davies, N. M.; Rades, T.; Tucker, I. G. Preparation of biodegradable insulin nanocapsules from biocompatible microemulsions. Pharm. Res., 2000, 17(6), 684-689.
5. Damge, C.; Vranckx, H.; Balschmidt, P.; Couvreur, P. Poly(alkylcyanoacrylate) nanospheres for oral administration of insulin. J.Pharm. Sci., 1997, 86(12), 1403-1409.
6. Lowe, P. J.; Temple, C. S. Calcitonin and insulin in isobutylcya-noacrylate nanocapsules - Protection against proteases and effecton intestinal absorption in rats. J. Pharm. Pharmacol., 1994, 46(7),547-552.
7. Constantinides, P. P.; Lancaster, C. M.; Marcello, J.; Chiossone, D.C.; Orner, D.; Hidalgo, I.; Smith, P. L.; Sarkahian, A. B.; Yiv, S.H.; Owen, A. J. Enhanced intestinal absorption of an RGD peptidefrom water-in-oil microemulsions of different composition and par-ticle size. J. Control. Release, 1995, 34(2), 109-116.
8. des Rieux, A.; Fievez, V.; Garinot, M.; Schneider, Y. J.; Preat, V.Nanoparticles as potential oral delivery systems of proteins andvaccines: A mechanistic approach. J. Control. Release, 2006,116(1), 1-27.
9. Liang, M.; Davies, N. M.; Toth, I. Increasing entrapment of pep-tides within poly(alkyl cyanoacrylate) nanoparticles prepared fromwater-in-oil microemulsions by copolymerization. Int. J. Pharm.,2008, 362(1-2), 141-146.
10. Pitaksuteepong, T.; Davies, N. M.; Tucker, I. G.; Rades, T. Factorsinfluencing the entrapment of hydrophilic compounds in nanocap-sules prepared by interfacial polymerisation of water-in-oil micro-emulsions. Eur. J. Pharm. Biopharm., 2002, 53(3), 335-342.
11. Fawaz, F.; Guyot, M.; Lagueny, A. M.; Devissaguet, J. P. Cipro-flexacin-loaded polyisobutylcyanoacrylate nanoparticles: prepara-tion and characterization. Int. J. Pharm., 1997, 154(2), 191-203.
12. 6-GnRH: Potential for copolymeriza-tion in polymeric nanoparticles. Mol. Pharm., 2009, 6(5), 1483-1491.
13. Hillery, A. M.; Toth, I.; Shaw, A. J.; Florence, A. T. Co-polymerised peptide particles (CPP).1. Synthesis, characterisationand in vitro studies on a novel oral nanoparticulate delivery system.J. Control. Release, 1996, 41(3), 271-281.
14. Grangier, J. L.; Puygrenier, M.; Gautier, J. C.; Couvreur, P.Nanoparticles as carriers for growth-hormone releasing-factor. J.Control. Release, 1991, 15(1), 3-13.
15. Singh, M.; Chakrapani, A.; O'Hagon, D. Nanoparticles and mi-croparticles as vaccine-delivery systems. Expert Rev. Vaccines,2007, 6(5), 797-808.
16. Bootz, A.; Russ, T.; Gores, F.; Karas, M.; Kreuter, J. Molecularweights of poly(butyl cyanoacrylate) nanoparticles determined bymass spectrometry and size exclusion chromatography. Eur. J.Pharm. Biopharm., 2005, 60(3), 391-399.
17. Biemann, K. Nomenclature for peptide fragment ions (positive-ions). Method Enzymol., 1990, 193, 886-887.
18. Smith, G. D.; Pangborn, W. A.; Blessing, R. H. The structure of T6human insulin at 1.0 A resolution. Acta Crystallogr. D Biol. Crys-tallogr., 2003, 59(3), 474-482.
19. Smith, G. D.; Ciszak, E.; Magrum, L. A.; Pangborn, W. A.; Bless-ing, R. H. R-6 hexameric insulin complexed with m-cresol or re-sorcinol. Acta Crystallogr. Sect. D-Biol. Crystallogr., 2000, 56,1541-1548.
20. Dunn, M. F. Zinc-ligand interactions modulate assembly and stabil-ity of the insulin hexamer - a review. Biometals, 2005, 18(4), 295-303.
21. Whittingham, J. L.; Edwards, D. J.; Antson, A. A.; Clarkson, J. M.;Dodson, C. G. Interactions of phenol and m-cresol in the insulinhexamer, and their effect on the association properties of B28 Pro -> Asp insulin analogues. Biochemistry, 1998, 37(33), 11516-11523.
22. Zoete, V.; Meuwly, M.; Karplus, M. Study of the insulin dimerization: Binding free energy calculations and per-residue free energydecomposition. Proteins, 2005, 61(1), 79-93.
23. Hua, Q. X. Insight into folding, binding and stability of insulin byNMR. Prog. Biochem. Biophys., 2004, 31(1), 1-26.
24. Brange, J.; Volund, A. Insulin analogs with improved pharmacoki-netic profiles. Adv. Drug Deliv. Rev., 1999, 35(2-3), 307-335.
25. Blundell, T. Conformation and molecular-biology of polypeptidehormones: 1. Insulin, insulin-like growth factor and relaxin. TrendsBiochem. Sci., 1979, 4(3), 51-54.
26. Graf, A.; McDowell, A.; Rades, T. Poly(alkycyanoacrylate)nanoparticles for enhanced delivery of therapeutics - is there realpotential? Expert Opin. Drug Deliv., 2009, 6(4), 371-387.